Phase II trial of seridopine as adjunctive therapy in patients with schizophrenia.

Trial Profile

Phase II trial of seridopine as adjunctive therapy in patients with schizophrenia.

Planning
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2011

At a glance

  • Drugs Seridopidine (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Sponsors NeuroSearch
  • Most Recent Events

    • 28 Apr 2011 Planned initiation date changed to 1 Dec 2011.
    • 02 May 2010 According to a NeuroSearch media release, planning and preparation for the trial is almost finalised.
    • 02 May 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top